ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 404 filers reported holding ENCOMPASS HEALTH CORP in Q1 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,260 | +27.1% | 8,000 | +28.2% | 0.00% | 0.0% |
| Q2 2023 | $422,588 | +24.7% | 6,241 | -0.4% | 0.00% | +50.0% |
| Q1 2023 | $338,943 | -10.5% | 6,265 | -1.1% | 0.00% | -33.3% |
| Q4 2022 | $378,903 | +55.9% | 6,335 | +85.2% | 0.00% | 0.0% |
| Q1 2022 | $243,000 | +13.6% | 3,421 | +4.5% | 0.00% | 0.0% |
| Q4 2021 | $214,000 | -15.7% | 3,274 | -3.4% | 0.00% | 0.0% |
| Q3 2021 | $254,000 | -3.8% | 3,388 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $264,000 | +10.0% | 3,383 | +15.3% | 0.00% | -20.0% |
| Q1 2021 | $240,000 | -3.6% | 2,935 | -2.6% | 0.01% | -16.7% |
| Q4 2020 | $249,000 | +18.0% | 3,013 | -7.2% | 0.01% | +20.0% |
| Q3 2020 | $211,000 | -5.8% | 3,248 | -10.2% | 0.01% | -16.7% |
| Q2 2020 | $224,000 | -3.4% | 3,617 | 0.0% | 0.01% | -25.0% |
| Q1 2020 | $232,000 | -7.6% | 3,617 | 0.0% | 0.01% | +14.3% |
| Q4 2019 | $251,000 | – | 3,617 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |